{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:54:54Z","timestamp":1781110494012,"version":"3.54.1"},"reference-count":42,"publisher":"National Academy of Sciences","issue":"37","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2008,9,16]]},"abstract":"<jats:p>\n                    Diisopropyl fluorophosphate (DFP) causes neurotoxicity related to an irreversible inhibition of acetylcholinesterase (AChE). Management of this intoxication includes: (\n                    <jats:italic>i<\/jats:italic>\n                    ) pretreatment with reversible blockers of AChE, (\n                    <jats:italic>ii<\/jats:italic>\n                    ) blockade of muscarinic receptors with atropine, and (\n                    <jats:italic>iii<\/jats:italic>\n                    ) facilitation of GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptor signal transduction by benzodiazepines. The major disadvantage associated with this treatment combination is that it must to be repeated frequently and, in some cases, protractedly. Also, the use of diazepam (DZP) and congeners includes unwanted side effects, including sedation, amnesia, cardiorespiratory depression, and anticonvulsive tolerance. To avoid these treatment complications but safely protect against DFP-induced seizures and other CNS toxicity, we adopted the strategy of administering mice with (\n                    <jats:italic>i<\/jats:italic>\n                    ) small doses of huperzine A (HUP), a reversible and long-lasting (half-life \u22485 h) inhibitor of AChE, and (\n                    <jats:italic>ii<\/jats:italic>\n                    ) imidazenil (IMI), a potent positive allosteric modulator of GABA action selective for \u03b1\n                    <jats:sub>5<\/jats:sub>\n                    -containing GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptors. Coadministration of HUP (50 \u03bcg\/kg s.c., 15 min before DFP) with IMI (2 mg\/kg s.c., 30 min before DFP) prevents DFP-induced convulsions and the associated neuronal damage and mortality, allowing complete recovery within 18\u201324 h. In HUP-pretreated mice, the ED\n                    <jats:sub>50<\/jats:sub>\n                    of IMI to block DFP-induced mortality is \u224810 times lower than that of DZP and is devoid of sedation. Our data show that a combination of HUP with IMI is a prophylactic, potent, and safe therapeutic strategy to overcome DFP toxicity.\n                  <\/jats:p>","DOI":"10.1073\/pnas.0807172105","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:43:41Z","timestamp":1221083021000},"page":"14169-14174","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":26,"title":["The combination of huperzine A and imidazenil is an effective strategy to prevent diisopropyl fluorophosphate toxicity in mice"],"prefix":"10.1073","volume":"105","author":[{"given":"Fabio","family":"Pibiri","sequence":"first","affiliation":[{"name":"*Psychiatric Institute, Department of Psychiatry, College of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P.","family":"Kozikowski","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, University of Illinois, Chicago, IL 60612"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Pinna","sequence":"additional","affiliation":[{"name":"*Psychiatric Institute, Department of Psychiatry, College of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Auta","sequence":"additional","affiliation":[{"name":"*Psychiatric Institute, Department of Psychiatry, College of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashkim","family":"Kadriu","sequence":"additional","affiliation":[{"name":"*Psychiatric Institute, Department of Psychiatry, College of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erminio","family":"Costa","sequence":"additional","affiliation":[{"name":"*Psychiatric Institute, Department of Psychiatry, College of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Guidotti","sequence":"additional","affiliation":[{"name":"*Psychiatric Institute, Department of Psychiatry, College of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2008,9,16]]},"reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1115436"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/166.suppl_2.21"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/63.6.736"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7476.1231"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-813X(02)00015-3"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2003.09.010"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00697391"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(93)90472-6"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(90)90332-C"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00501-X"},{"key":"e_1_3_3_11_2","first-page":"CD001499","article-title":"Physostigmine for Alzheimer's disease","volume":"2","author":"Coelho F","year":"2001","unstructured":"F Coelho, J Birks, Physostigmine for Alzheimer's disease. Cochrane Database Syst Rev 2, CD001499 (2001).","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(96)83115-7"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(97)00511-X"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jat.2550150406"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(99)00171-9"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1006\/faat.1994.1065"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07434-2"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1081\/DCT-100102607"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1081\/DCT-100102608"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/jat.2550140502"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.14.6889"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00116a010"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(92)90649-6"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-813X(00)00015-2"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-2212-8"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-3565(25)38411-9","article-title":"Imidazenil: A new partial positive allosteric modulator of \u03b3-aminobutyric acid (GABA) action at GABAA receptors","volume":"266","author":"Giusti P","year":"1993","unstructured":"P Giusti, et al., Imidazenil: A new partial positive allosteric modulator of \u03b3-aminobutyric acid (GABA) action at GABAA receptors. J Pharmacol Exp Ther 266, 1018\u20131028 (1993).","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_27_2","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0022-3565(25)22535-6","article-title":"Imidazenil, a partial positive allosteric modulator of GABAA receptors, exhibits low tolerance and dependence liabilities in the rat","volume":"270","author":"Auta J","year":"1994","unstructured":"J Auta, P Giusti, A Guidotti, E Costa, Imidazenil, a partial positive allosteric modulator of GABAA receptors, exhibits low tolerance and dependence liabilities in the rat. J Pharmacol Exp Ther 270, 1262\u20131269 (1994).","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-199506000-00003"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.5.2314"},{"key":"e_1_3_3_30_2","first-page":"227","volume-title":"Handbook of Experimental Pharmacology","author":"Costa E","year":"2001","unstructured":"E Costa, J Auta, A Guidotti, Tolerance and dependence on ligands of the benzodiazepine sites expressed by GABAA receptors. Handbook of Experimental Pharmacology, ed H Mohler (Springer, Berlin) Vol 150, 227\u2013250 (2001)."},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0026-895X(25)09071-6","article-title":"Modifications of \u03b3-aminobutyric acid A receptor subunit expression in rat neocortex during tolerance to diazepam","volume":"49","author":"Impagnatiello F","year":"1996","unstructured":"F Impagnatiello, et al., Modifications of \u03b3-aminobutyric acid A receptor subunit expression in rat neocortex during tolerance to diazepam. Mol Pharmacol 49, 822\u2013831 (1996).","journal-title":"Mol Pharmacol"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033323"},{"key":"e_1_3_3_33_2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0022-3565(25)09636-3","article-title":"Imidazenil, a new anxiolytic and anticonvulsant drug, attenuates a benzodiazepine-induced cognition deficit in monkeys","volume":"273","author":"Thompson DM","year":"1995","unstructured":"DM Thompson, J Auta, A Guidotti, E Costa, Imidazenil, a new anxiolytic and anticonvulsant drug, attenuates a benzodiazepine-induced cognition deficit in monkeys. J Pharmacol Exp Ther 273, 1307\u20131312 (1995).","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_34_2","first-page":"396","article-title":"Pharmacokinetics of tablet huperzine A in six volunteers","volume":"16","author":"Qian BC","year":"1995","unstructured":"BC Qian, et al., Pharmacokinetics of tablet huperzine A in six volunteers. Acta Pharmacol Sin 16, 396\u2013398 (1995).","journal-title":"Acta Pharmacol Sin"},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3565(25)20479-7","article-title":"Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates","volume":"259","author":"Broomfield CA","year":"1991","unstructured":"CA Broomfield, et al., Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J Pharmacol Exp Ther 259, 633\u2013638 (1991).","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/jat.805"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(96)10015-8"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/44579"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801853105"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1037\/h0027676"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.6.2719"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0013-4694(72)90177-0"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.0807172105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T17:11:40Z","timestamp":1738343500000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.0807172105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,16]]},"references-count":42,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2008,9,16]]}},"alternative-id":["10.1073\/pnas.0807172105"],"URL":"https:\/\/doi.org\/10.1073\/pnas.0807172105","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,16]]},"assertion":[{"value":"2008-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-09-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}